EX-23.1 6 tm243190d16_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated February 28, 2024, relating to the consolidated financial statements of Inhibrx, Inc. appearing in the Registration Statement on Form 10 of Inhibrx Biosciences, Inc.

 

/s/BDO USA, P.C.

 

San Diego, California

May 30, 2024